Self-Management Support for Insulin Therapy in Type 2 Diabetes
- 1 March 2004
- journal article
- research article
- Published by SAGE Publications in The Diabetes Educator
- Vol. 30 (2) , 274-280
- https://doi.org/10.1177/014572170403000220
Abstract
The purpose of this article is to describe the self-management support that can be provided by diabetes educators for type 2 diabetes patients who are transitioning from therapy with oral hypoglycemic agents to insulin. The role of the diabetes educator in patient education and self-management support during all aspects of insulin therapy is discussed. Phases during which support may be especially important include the decision-making process, initiation, and maintenance. Although some patients make the decision fairly easily, the introduction of insulin therapy is likely to raise many issues and questions for many type 2 diabetes patients. The more reluctant patients may experience psychological insulin resistance, a syndrome where insulin therapy is viewed as a threat or failure, which can affect health professionals as well. The diabetes educator can provide support and approaches to help diminish this resistance and make the transition to insulin therapy easier and more effective for patients with type 2 diabetes. Education and ongoing self-management support are needed for informed decision making and the initiation and maintenance of insulin therapy. Therefore, diabetes educators have a critical role to play during both the decision-making process and the safe transition to insulin therapy.Keywords
This publication has 16 references indexed in Scilit:
- Report CardDiabetes Care, 2004
- Glimepiride Combined with Morning Insulin Glargine, Bedtime Neutral Protamine Hagedorn Insulin, or Bedtime Insulin Glargine in Patients with Type 2 DiabetesAnnals of Internal Medicine, 2003
- When oral agents fail: practical barriers to starting insulinInternational Journal of Obesity, 2002
- Before oral agents fail: the case for starting insulin earlyInternational Journal of Obesity, 2002
- The DAWN (Diabetes Attitudes, Wishes and Needs) studyPractical Diabetes International, 2002
- Physiological insulin replacement in type 1 diabetes mellitusExperimental and Clinical Endocrinology & Diabetes, 2001
- Management of diabetes: are doctors framing the benefits from the wrong perspective?BMJ, 2001
- Health Economic Benefits and Quality of Life During Improved Glycemic Control in Patients With Type 2 Diabetes MellitusJAMA, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- NIDDM Patients' Fears and Hopes About Insulin Therapy: The basis of patient reluctanceDiabetes Care, 1997